Insiders have sold 80,784 shares of company stock worth $10,961,334 in the last ninety days. The health care company reported $1.14M value for the 2017Q4. Altrinsic Global Advisors Llc who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be bullish on the $24.77 billion market cap company. About 1.11M shares traded.
Shares of Alexion Pharmaceuticals stock traded up $0.09 during trading on Friday, hitting $111.38. ALXN underperformed by 20.39% the S&P500. Inc. for a number of months, seems to be bullish on the $154.14 billion market cap company.
Martin D. Sass decreased its stake in Covanta Hldg Corp (CVA) by 12.43% based on its latest 2017Q4 regulatory filing with the SEC. National Bank Of America Corporation De invested in 3,300 shares or 0% of the stock. The stock increased 0.45% or $0.35 during the last trading session, reaching $77.9. (NASDAQ:ALXN). Public Employees Retirement Association Of Colorado has invested 0.03% in Alexion Pharmaceuticals, Inc. It has underperformed by 39.42% the S&P500. Covanta had 50 analyst reports since October 8, 2015 according to SRatingsIntel. (NYSE:MRK), 19 have Buy rating, 0 Sell and 5 Hold. Therefore 63% are positive. The company was initiated on Wednesday, April 6 by Societe Generale. The stock of AcelRx Pharmaceuticals, Inc. The company was upgraded on Monday, July 11 by Credit Suisse. On Friday, February 9 the firm earned "Buy" rating by Citigroup. The firm has "Equal-Weight" rating given on Tuesday, August 9 by Barclays Capital. Jefferies has "Hold" rating and $121.0 target. In Thursday, March 15 report Robert W. Baird maintained it with "Buy" rating and $160.0 target. Blair William And Il holds 2,830 shs or 0% of its capital. The biopharmaceutical company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.25 by $0.01. It increased, as 27 investors sold MLNX shares while 37 reduced holdings. 123 funds opened positions while 558 raised stakes. The New York-based Virtu Fincl Lc has invested 0.01% in AcelRx Pharmaceuticals, Inc. (NYSE:MRK). Waddell Reed has 162,890 shares. Apg Asset Management Nv reported 64,532 shs. Following the transaction, the senior vice president now directly owns 32,635 shares in the company, valued at approximately $3,826,780.10. Prudential Public Ltd Company reported 176,868 shares. Following the completion of the transaction, the chief executive officer now directly owns 131,425 shares in the company, valued at $15,286,041.75. Ngam Advisors Ltd Partnership invested in 18,953 shs or 0.02% of the stock. (NYSE:AMBR) for 21,718 shares. Private Trust Na reported 58,227 shares. (NYSE:MRK) for 252,565 shares. 2,619 are held by Hbk Invests Lp.
Total analysts of 14 have positions in Alexion Pharmaceuticals (NASDAQ:ALXN) as follows: 13 rated it a "Buy", 0 with "Sell" and 1 with "Hold". (NASDAQ:ACRX). Moreover, Royal Retail Bank Of Canada has 0% invested in AcelRx Pharmaceuticals, Inc. (NYSE:MRK) for 54.24M shares.
Investors sentiment decreased to 1.03 in Q4 2017. Its up 0.13, from 0.95 in 2017Q3. 64 funds took holdings and 178 increased holdings. 204.38 million shares or 1.21% less from 206.89 million shares in 2017Q3 were reported. Hudock Ltd Liability Company has invested 0.01% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is awaited On April, 26., RTT reports. (NASDAQ:ALXN) for 5,747 shs. Opus Point Partners Management Llc has risen its stake in and also increased its holding in by shares in the quarter, for a total of shares. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new position in Alexion Pharmaceuticals in the fourth quarter worth $502,000. (NASDAQ:ALXN). Fincl Engines Advsrs Ltd Liability Co owns 9 shares or 0% of their United States portfolio. Reliance Of Delaware owns 0.1% invested in Alexion Pharmaceuticals, Inc. Wells Fargo And Mn has invested 0% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Millennium Mgmt Limited Com reported 36,694 shares. Webster Commercial Bank N A holds 0.16% of its capital in Alexion Pharmaceuticals, Inc.
Since January 2, 2018, it had 0 buys, and 12 insider sales for $4.62 million activity. On Monday, February 5 O'Neill Julie sold $248,474 worth of Alexion Pharmaceuticals, Inc. Also, CEO Ludwig Hantson sold 13,245 shares of the firm's stock in a transaction dated Thursday, February 8th. The insider Clancy Paul J sold $707,048.
In related news, EVP John B. Moriarty sold 1,261 shares of the stock in a transaction on Monday, February 5th. (NASDAQ:ALXN) earned "Overweight" rating by Morgan Stanley on Thursday, May 25. 1,459 shares were sold by Franchini Indrani Lall, worth $169,696. $83,305 worth of Alexion Pharmaceuticals, Inc. The rating was downgraded by Raymond James on Thursday, January 4 to "Outperform". The rating was maintained by Imperial Capital with "Outperform" on Thursday, April 28. Wisconsin-based Northwestern Mutual Wealth Management has invested 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) rating. Stifel Nicolaus has "Buy" rating and $159 target. The company was maintained on Thursday, March 15 by Robert W. Baird. Cowen & Co maintained AcelRx Pharmaceuticals, Inc. The firm has "Buy" rating by Jefferies given on Friday, October 30. Cowen & Co maintained the shares of ACRX in report on Tuesday, August 1 with "Hold" rating. As per Friday, July 31, the company rating was maintained by UBS.
Premier Asset Managment Llc, which manages about $447.77M US Long portfolio, upped its stake in Intuitive Surgical Inc (NASDAQ:ISRG) by 17,041 shares to 26,369 shares, valued at $9.62M in 2017Q4, according to the filing. (NASDAQ:ACRX). Cornerstone holds 40,000 shares or 0.01% of its portfolio.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
15 April 2018
15 April 2018
15 April 2018
